Efficacy and Safety of Vorapaxar in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Undergoing Noncardiac Surgery.

Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med (1977) 8.24

Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation (1999) 8.17

Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.29

Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA (2013) 3.88

Coronary artery stents and non-cardiac surgery. Br J Anaesth (2007) 3.52

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med (2011) 3.20

Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol (2003) 3.13

Coronary artery stenting and non-cardiac surgery--a prospective outcome study. Br J Anaesth (2006) 3.08

Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol (2000) 3.01

Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med (2005) 2.98

Implementation of the third universal definition of myocardial infarction after coronary artery bypass grafting: a survey study in Western Europe. J Am Heart Assoc (2015) 2.78

Reinfarction following anesthesia in patients with myocardial infarction. Anesthesiology (1983) 2.36

Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients. Circulation (2011) 2.30

Frequency and risk of noncardiac surgery after drug-eluting stent implantation. Catheter Cardiovasc Interv (2011) 2.18

Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med (1986) 2.13

The incremental risk of noncardiac surgery on adverse cardiac events following coronary stenting. J Am Coll Cardiol (2014) 2.10

Non-cardiac surgery in patients with coronary stents: the RECO study. Heart (2011) 2.10

ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol (2007) 2.04

Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv (2010) 1.75

Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg (1996) 1.73

Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology (2008) 1.71

Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study. Circulation (2012) 1.67

Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. Br J Anaesth (2011) 1.65

Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome). J Am Coll Cardiol (2013) 1.51

To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth (2010) 1.49

Risk of surgery following recent myocardial infarction. Ann Surg (2011) 1.47

Multicenter prospective study of nonruptured abdominal aortic aneurysm. Part II. Variables predicting morbidity and mortality. J Vasc Surg (1989) 1.37

Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest (2006) 1.25

The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale. Am Heart J (2009) 1.16

The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet (1993) 1.08

Risks of noncardiac surgery after coronary stenting. Am J Cardiol (2005) 1.01

Outcomes in heart failure patients after major noncardiac surgery. J Am Coll Cardiol (2004) 1.01

Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. JACC Cardiovasc Interv (2010) 0.97

Noncardiac surgery and bleeding after percutaneous coronary intervention. Circ Cardiovasc Interv (2009) 0.89

Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery. Circulation (2013) 0.88

Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: results from the Evaluation of Drug-Eluting Stents and Ischemic Events Registry. Am Heart J (2011) 0.81

Perioperative complications in patients with drug-eluting stents: a three-year audit at Geelong Hospital. Anaesth Intensive Care (2007) 0.78

Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER. J Am Heart Assoc (2014) 0.77